Day: May 7, 2020

LAKEWOOD, NJ, May 07, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Reliance Global Group, Inc. (OTCQB: RELI) (“RELI” or the “Company”), today reported that the Company has completed the 2019 audit, including its wholly owned subsidiaries.  The audit results are available on the OTC’s website.  In addition, the Company is well underway preparing and plans to file its Form 10 with the Securities and Exchange Commission, to become a fully reporting company.Ezra Beyman, CEO of Reliance Global Group, stated, “The filing of our 2019 audited financial results is an important milestone, and reflects the consolidated results of our recent acquisitions.  As expected, our results reflect strong growth.  Even including the results of operations for the periods preceding the acquisitions, our pro forma revenue reflects...

In connection with PWT Holding A/S’ subsidiary, PWT Group A/S’, ongoing restructuring, PWT Group A/S has made certain information available to its creditors. The information is available here.For further information, please contactPWT Holding A/SOle Koch Hansen, CEOTelephone: +45 40444130E-mail: ole@pwtgroup.dkClaus Back Nielsen, CFOTelephone: +45 25434611E-mail: cbn@pwtgroup.dkInformation: This information is information that PWT Holding A/S is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication at 19,15 on 7 May 2020.AttachmentsPWT Holding AS – Company announcement – Information to PWT Group AS’ creditors (2020-05-07)Creditorinformation no 2 with schedule 1-7Kreditorinformation nr. 2 m bilag 1-7

CE COMMUNIQUÉ DE PRESSE NE DOIT PAS ÊTRE DISTRIBUÉ AUX AGENCES DE PRESSE AMÉRICAINES ET NE DOIT PAS ÊTRE DIFFUSÉ AUX ÉTATS-UNISVANCOUVER, Colombie-Britannique, 07 mai 2020 (GLOBE NEWSWIRE) —  Euro Manganese Inc. (TSX-V / ASX : EMN) (la « Société » ou « EMN ») est ravie d’annoncer que, suite à l’approbation par 100 % des actionnaires qui ont voté lors d’une réunion spéciale qui s’est tenue le 1er mai 2020, elle a clôturé la deuxième tranche du placement privé sans courtier (l’« Offre »), qui a été annoncée le 24 mars 2020.La deuxième tranche de l’Offre (la « Tranche des parties liées ») était composée de souscriptions des parties liées à la Société (comprenant des administrateurs de la Société et des Sociétés contrôlées par ceux-ci) de 4 261 142 actions ordinaires (les «Actions ») au prix de 0,11 dollar...

NICHT ZUR VERTEILUNG AN NACHRICHTENAGENTUREN DER VEREINIGTEN STAATEN ODER ZUR VERBREITUNG IN DEN VEREINIGTEN STAATENVANCOUVER, British Columbia, May 07, 2020 (GLOBE NEWSWIRE) — Euro Manganese Inc. (TSX-V/ASX: EMN) (das „Unternehmen“ oder „EMN“) freut sich, nach Zustimmung von 100 % der Aktionäre, die auf der außerordentlichen Aktionärsversammlung am 1. Mai 2020 abgestimmt haben, den Abschluss der am 24. März 2020 angekündigten zweiten Tranche der nicht durch einen Makler vermittelten Privatplatzierung (das „Angebot“) bekannt zu geben. Die zweite Tranche des Angebots (die „Tranche für verbundene Parteien“) bestand aus Zeichnungen durch verbundene Parteien des Unternehmens (Vorstandsmitglieder des Unternehmens und Unternehmen, die von Vorstandsmitgliedern des Unternehmens beherrscht werden) von 4.261.142 Stammaktien („Aktien“) zu...

SUPPLEMENT DATED 7 MAY 2020TO THE INFORMATION MEMORANDUM DATED 7 JUNE 2019Republic of IcelandU.S.$5,000,000,000Euro Medium Term Note ProgrammeThis supplement (the “Supplement“) is supplemental to, forms part of and must be read and construed in conjunction with, the information memorandum dated 7 June 2019 (the “Information Memorandum“), as may be further supplemented from time to time, prepared by the Republic of Iceland acting through the Ministry of Finance and Economic Affairs (the “Republic” or “Iceland“) in connection with its Euro Medium Term Note Programme (the “Programme“) for the issuance of notes (the “Notes“).Terms given a defined meaning in the Information Memorandum shall, unless the context otherwise requires, have the same meaning when used in this...

Reference is made to the announcement on May 4, 2020. Norsk Hydro ASA has today completed a successful placement of senior unsecured bonds with a total amount of NOK 7 billion. The transaction is split on four tranches:– 3 year NOK 2,250 million floating rate note with a coupon of 3m Nibor +2.90% p.a.– 5.75 year NOK 2,750 million floating rate note with a coupon of 3m Nibor +3.30% p.a.– 7 year NOK 1,000 million fixed rate note with a coupon of 4.00% p.a.– 10 year NOK 1,000 million fixed rate note with a coupon of 4.575% p.a.“We are very pleased with the process and to have completed a successful placement of bonds. This improves our already solid liquidity in an uncertain market caused by the Covid-19 pandemic. Interest from investors has been strong and we have accomplished competitive terms given current market...

Det vises til børsmelding den 4. mai 2020. Norsk Hydro ASA har i dag plassert nye usikrede obligasjonslån på totalt NOK 7 milliarder i fire ulike transjer:– 3 år NOK 2,250 millioner med flytende rente og kupong 3m Nibor + 2,90% p.a.– 5,75 år NOK 2,750 millioner med flytende rente og kupong 3m Nibor + 3,30% p.a.– 7 år NOK 1,000 millioner med fast rente og kupong 4,00% p.a.– 10 år NOK 1,000 millioner med fast rente og kupong 4,575% p.a.“Vi er meget fornøyd med prosessen og gjennomføringen av en vellykket plassering av obligasjonslån. Dette styrker vår allerede solide likviditet i et usikkert marked grunnet Covid-19-pandemien. Utstedelsen har møtt sterk interesse blant investorer og vi har oppnådd konkurransedyktige vilkår gitt nåværende markedsforhold”, sier finansdirektør Pål Kildemo.Som tidligere annonsert er formålet...

Paris, May 07, 2020, 7pmAB Science is hosting live webcast on Monday May 11, 2020 on masitinibin combination with isoquercetine for the treatment of COVID-19AB Science SA (NYSE Euronext – FR0010557264 – AB) will host a live webcast on Monday 11, 2020 following the recent authorization by the French Medicine Agency, ANSM, to initiate a Phase 2 study evaluating masitinib in combination with isoquercetin for the treatment of COVID-19.This study (AB20001) is a randomized (1:1), open-label Phase 2 clinical trial to evaluate the safety and efficacy of masitinib combined with isoquercetin in hospitalized patients with moderate and severe COVID-19. The study will enroll 200 patients (age ≥18 without an upper age limit) at medical centers in France and other countries. The primary objective is to improve the clinical status of patients...

Paris, 7 mai 2020, 19hAB Science tiendra une conférence web le lundi 11 mai 2020 sur le masitiniben combinaison avec l’isoquercétine dans le traitement du COVID-19AB Science SA (NYSE Euronext – FR0010557264 – AB) tiendra une conférence web le lundi 11 mai 2020, suite à la récente autorisation de l’Agence française du médicament, ANSM, d’initier une étude de phase 2 évaluant le masitinib en combinaison avec l’isoquercetine dans le traitement du COVID-19.Cette étude (AB20001) est une étude clinique de phase 2 randomisée (1:1), ouverte, visant à évaluer la tolérance et l’efficacité du masitinib associé à l’isoquercétine chez les patients hospitalisés atteints de COVID-19 modéré et sévère. L’étude recrutera 200 patients (âgés de plus de 18 ans et sans limite supérieure d’âge) dans des hôpitaux en...

KING CITY, Ontario, May 07, 2020 (GLOBE NEWSWIRE) — TWC Enterprises Limited (TSX:TWC) (“TWC”) announced the results of matters voted on at its Annual Shareholders Meeting held on May 6, 2020 (the “Meeting”), which included the election of Directors of the Corporation, all of the nominees listed in its management information circular dated April 1, 2020.  The voting results for each of the matters presented at the Meeting are presented below.There were 21 Shareholders holding 22,654,119 Common Shares represented in person or by proxy at this meeting. This represents 85.61% of the 26,460,951 issued and outstanding Common Shares.1.             Election of DirectorsThe eight (8) nominees proposed by management were elected as Directors of the Corporation to hold office until the termination of the next annual meeting of Shareholders or...